199 related articles for article (PubMed ID: 28799813)
21. Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival.
Tas F; Erturk K
Clin Transl Oncol; 2018 May; 20(5):607-612. PubMed ID: 28948477
[TBL] [Abstract][Full Text] [Related]
22. Presence of histological regression as a prognostic factor in cutaneous melanoma patients.
Tas F; Erturk K
Melanoma Res; 2016 Oct; 26(5):492-6. PubMed ID: 27380112
[TBL] [Abstract][Full Text] [Related]
23. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
24. A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring.
Saldanha G; Flatman K; Teo KW; Bamford M
Am J Surg Pathol; 2017 Jul; 41(7):906-914. PubMed ID: 28368925
[TBL] [Abstract][Full Text] [Related]
25. Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials.
Rao UN; Lee SJ; Luo W; Mihm MC; Kirkwood JM
Am J Clin Pathol; 2010 Apr; 133(4):646-53. PubMed ID: 20231618
[TBL] [Abstract][Full Text] [Related]
26. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma.
Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M
Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586
[TBL] [Abstract][Full Text] [Related]
27. An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma.
Acs B; Ahmed FS; Gupta S; Wong PF; Gartrell RD; Sarin Pradhan J; Rizk EM; Gould Rothberg B; Saenger YM; Rimm DL
Nat Commun; 2019 Nov; 10(1):5440. PubMed ID: 31784511
[TBL] [Abstract][Full Text] [Related]
28. Is There a Relationship Between TILs and Regression in Melanoma?
Morrison S; Han G; Elenwa F; Vetto JT; Fowler G; Leong SP; Kashani-Sabet M; Pockaj B; Kosiorek HE; Zager JS; Messina JL; Mozzillo N; Schneebaum S; Han D;
Ann Surg Oncol; 2022 May; 29(5):2854-2866. PubMed ID: 35064332
[TBL] [Abstract][Full Text] [Related]
29. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
31. Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome.
Tas F; Erturk K
Melanoma Res; 2017 Aug; 27(4):387-390. PubMed ID: 28234768
[TBL] [Abstract][Full Text] [Related]
32. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
33. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
34. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
35. Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.
Doepker MP; Thompson ZJ; Harb JN; Messina JL; Puleo CA; Egan KM; Sarnaik AA; Gonzalez RJ; Sondak VK; Zager JS
J Surg Oncol; 2016 Jan; 113(1):98-102. PubMed ID: 26661407
[TBL] [Abstract][Full Text] [Related]
36. High percentage of ADAM-10 positive melanoma cells correlates with paucity of tumor-infiltrating lymphocytes but does not predict prognosis in cutaneous melanoma patients.
Donizy P; Zietek M; Leskiewicz M; Halon A; Matkowski R
Anal Cell Pathol (Amst); 2015; 2015():975436. PubMed ID: 26266086
[TBL] [Abstract][Full Text] [Related]
37. Comparison of five different scoring methods in the evaluation of inflammatory infiltration (tumor-infiltrating lymphocytes) in superficial spreading and nodular melanoma.
Němejcová K; Tichá I; Bártů M; Kodet O; Důra M; Jakša R; Michálková R; Dundr P
Pigment Cell Melanoma Res; 2019 May; 32(3):412-423. PubMed ID: 30506645
[TBL] [Abstract][Full Text] [Related]
38. Sarcopenia as a prognostic factor among patients with stage III melanoma.
Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
[TBL] [Abstract][Full Text] [Related]
39. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
[TBL] [Abstract][Full Text] [Related]
40. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas.
Lin RL; Wang TJ; Joyce CJ; Mihm MC; Murphy GF; Lian CG; Lin JY
Melanoma Res; 2016 Oct; 26(5):524-7. PubMed ID: 26974966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
